Spotlight on Bortezomib: potential in the treatment of hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Spotlight on Bortezomib: potential in the treatment of hepatocellular carcinoma

Published:2018-11-30 Issue:1 Volume:28 Page:7-18
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Huang I-Tao¹²,Dhungel Bijay¹²,Shrestha Ritu¹²,Bridle Kim R.¹²,Crawford Darrell H. G.¹²,Jayachandran Aparna¹²,Steel Jason C¹³

Affiliation:

1. School of Clinical Medicine, The University of Queensland, Brisbane, Australia

2. Gallipoli Medical Research Institute, Greenslopes Private Hospital, Brisbane, Australia

3. School of Health, Medical and Applied Sciences, CQ University, Rockhampton, Australia

Funder

Gallipoli Medical Research Foundation

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2019.1551359

Reference102 articles.

1. Cancer statistics, 2017

2. Hepatocellular carcinoma

3. Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis

4. Epidemiology of Hepatocellular Carcinoma

5. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Ubiquitination and Proteostasis in Retinal Degeneration;Frontiers in Bioscience-Landmark;2024-07-22

2. KLF15-activated MARCH2 boosts cell proliferation and epithelial-mesenchymal transition and presents diagnostic significance for hepatocellular carcinoma;Experimental Cell Research;2024-07

3. Histone‐lysine N‐methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc‐driven liver cancer;Molecular Oncology;2023-03-29

4. Potential Molecular Targeted Therapy for Unresectable Hepatocellular Carcinoma;Current Oncology;2023-01-18

5. Bortezomib inhibits hepatocellular carcinoma via the Hippo‐Yes‐associated protein signalling pathway;Basic & Clinical Pharmacology & Toxicology;2023-01-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3